Cereno Scientific announces US subsidiary in Cambridge, Boston, MA

13 May, 2020

Cereno Scientific develops innovative medicines for cardiovascular and rare diseases related to fibrosis, thrombosis, inflammation and high blood pressure in the lung as well as systemically. As a step towards a more international footprint, the Gothenburg based company has established a US subsidiary in Boston called Cereno Scientific Inc. This is in line with the company’s ambition to scale up collaborations and networks with business partners and potential investors across the Atlantic Ocean.

Read the full article on BioStock.